Recall: Hospira Daptomycin For Injection 500 Mg, Lyophilized Powder For Solution, Single Dose Vial
On 2018-07-13, the FDA announced that Hospira is conducting a recall on Daptomycin For Injection 500 Mg, Lyophilized Powder For Solution, Single Dose Vial due to a possible undetermined hazard. The recalled products were sold under the brand name(s) Hospira during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential undetermined hazard, including birth control capsules, acyclovir tablet, usp, 400mg, 50ct unit dose and more. Additionally, there have been 22 drug and medical device recalls due to other health hazards as well as 77 food recalls.
Company Contact Information:
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial
Brand Name(s): Hospira
Reason for Recall: Undetermined Hazard
Official Recall Date: 2018-06-28
Note: Although this recall announcement is dated 06/28/2018, it was not published by the FDA until 07/13/2018.
Additional information provided by the FDA.gov:
Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira's Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.